Shares of our common stock are listed on the NASDAQ OTC market and trade under the symbol “UEEC“.
For more information, please contact investor@uhpcorp.com
For press and media relations, please contact media@uhpcorp.com
Press Releases
-
United Health Products Provides Update on FDA PMA Application
Mesquite, Nevada – Nov 28, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application. UHP continues to advance its Premarket Approval application with the Food and Drug Administration. As described in its October 31 press release, the company has completed its review and documentation […]
-
United Health Products Provides Update on FDA PMA Application
Mesquite, NV, – Oct. 31, 2022 – United Health Products, Inc. (OTCPK: UEEC) (UHP), today provided an update on the company’s FDA Premarket Approval application and financial reporting calendar. As previously disclosed in its press release of September 6th, UHP continues to assemble required documentation and test its manufacturing process to complete its FDA application for […]
-
United Health Products Announces Equity Financing Agreement and Provides Corporate Update
Mesquite, Nevada – September 6, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today announced that it has entered into a common stock purchase agreement to sell up to $10 million of shares to White Lion Capital, LLC (White Lion), a California-based institutional investor. Under the terms of the purchase agreement, UHP will have the […]
-
United Health Products Provides Update on FDA Review
Henderson, Nevada – July 15, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application. On July 13 the company and its regulatory consultant met with the full FDA team assigned to review its Class III PMA application. The focus of the meeting was […]